Monitoring populations for DNA repair deficiency and for cancer susceptibility

William W. Au, Gregg S. Wilkinson, Stephen K. Tyring, Marvin S. Legator, Randa El Zein, Lance Hallberg, Moon Y. Heo

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The induction of a mutator phenotype has been hypothesized to cause the accumulation of multiple mutations in the development of cancer. Recent evidence suggests that the mutator phenotype is associated with DNA repair deficiencies. We have been using a challenge assay to study exposed populations to test our hypothesis that exposure to environmental toxicants can induce DNA repair deficiency in somatic cells. In this assay, lymphocytes were irradiated in vitro to challenge cells to repair the radiation-induced DNA strand breaks. An increase of chromosome aberrations in the challenged cells from toxicant-exposed populations compared to nonexposed populations is used to indicate abnormal DNA repair response. From studies of cigarette smokers, butadiene-exposed workers, and uranium-exposed residents, the assay showed that these exposed populations had mutagen-induced abnormal DNA repair response. The phenomenon was also demonstrated using experimental animals. Mice were exposed in vivo to two different doses of N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) and their lymphocytes were challenged with one dose of a radiomimetic chemical, bleomycin, in vitro. These challenged lymphocytes showed an MNNG dose-dependent increase of abnormal DNA repair response. In a population that was potentially exposed to teratogens - mothers having children with neural tube defects - lymphocytes from these mothers did not have the abnormal response in our assay. In studies with patients, we reported that lymphocytes from Down's syndrome patients have the abnormal DNA repair response. Lymphocytes from skin cancer-prone patients (epidermodysplasia verruciformis) have normal response to γ-ray challenge but abnormal response to UV-light challenge. These patient studies also indicate that the challenge assay is useful in documenting the radiosensitivity of Down's syndrome and the UV sensitivity in EV patients. In most cases, the challenge assay is more sensitive in detecting biological effects than the standard chromosome aberration assay. Our series of studies indicates that the challenge assay can be used to document biological effects from exposure to mutagens and that the effect is an abnormal DNA repair response. This abnormality can increase the risk for development of cancer. The repair deficiency is currently being validated using a plasmid transfection (host-reactivaton) assay. The need to integrate chromosome aberration and the challenge assays with other relevant assays for better documentation of biological effects and for more precise prediction of health risk will be presented. Our experience in using genetic polymorphism and host-reactivation assays will be discussed.

Original languageEnglish (US)
Pages (from-to)579-584
Number of pages6
JournalEnvironmental Health Perspectives
Volume104
Issue numberSUPPL. 3
StatePublished - May 1996

Fingerprint

DNA Repair-Deficiency Disorders
repair
cancer
Assays
Repair
DNA Repair
assay
Lymphocytes
DNA
Monitoring
monitoring
Chromosome Aberrations
Population
Neoplasms
Mutagens
Down Syndrome
Chromosomes
Epidermodysplasia Verruciformis
Aberrations
Mothers

Keywords

  • Cancer susceptibility
  • Chromosome aberrations
  • DNA repair
  • Environmental toxicology
  • Genotoxicity
  • Predisposition

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Au, W. W., Wilkinson, G. S., Tyring, S. K., Legator, M. S., El Zein, R., Hallberg, L., & Heo, M. Y. (1996). Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environmental Health Perspectives, 104(SUPPL. 3), 579-584.

Monitoring populations for DNA repair deficiency and for cancer susceptibility. / Au, William W.; Wilkinson, Gregg S.; Tyring, Stephen K.; Legator, Marvin S.; El Zein, Randa; Hallberg, Lance; Heo, Moon Y.

In: Environmental Health Perspectives, Vol. 104, No. SUPPL. 3, 05.1996, p. 579-584.

Research output: Contribution to journalArticle

Au, WW, Wilkinson, GS, Tyring, SK, Legator, MS, El Zein, R, Hallberg, L & Heo, MY 1996, 'Monitoring populations for DNA repair deficiency and for cancer susceptibility', Environmental Health Perspectives, vol. 104, no. SUPPL. 3, pp. 579-584.
Au WW, Wilkinson GS, Tyring SK, Legator MS, El Zein R, Hallberg L et al. Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environmental Health Perspectives. 1996 May;104(SUPPL. 3):579-584.
Au, William W. ; Wilkinson, Gregg S. ; Tyring, Stephen K. ; Legator, Marvin S. ; El Zein, Randa ; Hallberg, Lance ; Heo, Moon Y. / Monitoring populations for DNA repair deficiency and for cancer susceptibility. In: Environmental Health Perspectives. 1996 ; Vol. 104, No. SUPPL. 3. pp. 579-584.
@article{53064efcdd574738a6b8dd029102f2de,
title = "Monitoring populations for DNA repair deficiency and for cancer susceptibility",
abstract = "The induction of a mutator phenotype has been hypothesized to cause the accumulation of multiple mutations in the development of cancer. Recent evidence suggests that the mutator phenotype is associated with DNA repair deficiencies. We have been using a challenge assay to study exposed populations to test our hypothesis that exposure to environmental toxicants can induce DNA repair deficiency in somatic cells. In this assay, lymphocytes were irradiated in vitro to challenge cells to repair the radiation-induced DNA strand breaks. An increase of chromosome aberrations in the challenged cells from toxicant-exposed populations compared to nonexposed populations is used to indicate abnormal DNA repair response. From studies of cigarette smokers, butadiene-exposed workers, and uranium-exposed residents, the assay showed that these exposed populations had mutagen-induced abnormal DNA repair response. The phenomenon was also demonstrated using experimental animals. Mice were exposed in vivo to two different doses of N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) and their lymphocytes were challenged with one dose of a radiomimetic chemical, bleomycin, in vitro. These challenged lymphocytes showed an MNNG dose-dependent increase of abnormal DNA repair response. In a population that was potentially exposed to teratogens - mothers having children with neural tube defects - lymphocytes from these mothers did not have the abnormal response in our assay. In studies with patients, we reported that lymphocytes from Down's syndrome patients have the abnormal DNA repair response. Lymphocytes from skin cancer-prone patients (epidermodysplasia verruciformis) have normal response to γ-ray challenge but abnormal response to UV-light challenge. These patient studies also indicate that the challenge assay is useful in documenting the radiosensitivity of Down's syndrome and the UV sensitivity in EV patients. In most cases, the challenge assay is more sensitive in detecting biological effects than the standard chromosome aberration assay. Our series of studies indicates that the challenge assay can be used to document biological effects from exposure to mutagens and that the effect is an abnormal DNA repair response. This abnormality can increase the risk for development of cancer. The repair deficiency is currently being validated using a plasmid transfection (host-reactivaton) assay. The need to integrate chromosome aberration and the challenge assays with other relevant assays for better documentation of biological effects and for more precise prediction of health risk will be presented. Our experience in using genetic polymorphism and host-reactivation assays will be discussed.",
keywords = "Cancer susceptibility, Chromosome aberrations, DNA repair, Environmental toxicology, Genotoxicity, Predisposition",
author = "Au, {William W.} and Wilkinson, {Gregg S.} and Tyring, {Stephen K.} and Legator, {Marvin S.} and {El Zein}, Randa and Lance Hallberg and Heo, {Moon Y.}",
year = "1996",
month = "5",
language = "English (US)",
volume = "104",
pages = "579--584",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Monitoring populations for DNA repair deficiency and for cancer susceptibility

AU - Au, William W.

AU - Wilkinson, Gregg S.

AU - Tyring, Stephen K.

AU - Legator, Marvin S.

AU - El Zein, Randa

AU - Hallberg, Lance

AU - Heo, Moon Y.

PY - 1996/5

Y1 - 1996/5

N2 - The induction of a mutator phenotype has been hypothesized to cause the accumulation of multiple mutations in the development of cancer. Recent evidence suggests that the mutator phenotype is associated with DNA repair deficiencies. We have been using a challenge assay to study exposed populations to test our hypothesis that exposure to environmental toxicants can induce DNA repair deficiency in somatic cells. In this assay, lymphocytes were irradiated in vitro to challenge cells to repair the radiation-induced DNA strand breaks. An increase of chromosome aberrations in the challenged cells from toxicant-exposed populations compared to nonexposed populations is used to indicate abnormal DNA repair response. From studies of cigarette smokers, butadiene-exposed workers, and uranium-exposed residents, the assay showed that these exposed populations had mutagen-induced abnormal DNA repair response. The phenomenon was also demonstrated using experimental animals. Mice were exposed in vivo to two different doses of N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) and their lymphocytes were challenged with one dose of a radiomimetic chemical, bleomycin, in vitro. These challenged lymphocytes showed an MNNG dose-dependent increase of abnormal DNA repair response. In a population that was potentially exposed to teratogens - mothers having children with neural tube defects - lymphocytes from these mothers did not have the abnormal response in our assay. In studies with patients, we reported that lymphocytes from Down's syndrome patients have the abnormal DNA repair response. Lymphocytes from skin cancer-prone patients (epidermodysplasia verruciformis) have normal response to γ-ray challenge but abnormal response to UV-light challenge. These patient studies also indicate that the challenge assay is useful in documenting the radiosensitivity of Down's syndrome and the UV sensitivity in EV patients. In most cases, the challenge assay is more sensitive in detecting biological effects than the standard chromosome aberration assay. Our series of studies indicates that the challenge assay can be used to document biological effects from exposure to mutagens and that the effect is an abnormal DNA repair response. This abnormality can increase the risk for development of cancer. The repair deficiency is currently being validated using a plasmid transfection (host-reactivaton) assay. The need to integrate chromosome aberration and the challenge assays with other relevant assays for better documentation of biological effects and for more precise prediction of health risk will be presented. Our experience in using genetic polymorphism and host-reactivation assays will be discussed.

AB - The induction of a mutator phenotype has been hypothesized to cause the accumulation of multiple mutations in the development of cancer. Recent evidence suggests that the mutator phenotype is associated with DNA repair deficiencies. We have been using a challenge assay to study exposed populations to test our hypothesis that exposure to environmental toxicants can induce DNA repair deficiency in somatic cells. In this assay, lymphocytes were irradiated in vitro to challenge cells to repair the radiation-induced DNA strand breaks. An increase of chromosome aberrations in the challenged cells from toxicant-exposed populations compared to nonexposed populations is used to indicate abnormal DNA repair response. From studies of cigarette smokers, butadiene-exposed workers, and uranium-exposed residents, the assay showed that these exposed populations had mutagen-induced abnormal DNA repair response. The phenomenon was also demonstrated using experimental animals. Mice were exposed in vivo to two different doses of N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) and their lymphocytes were challenged with one dose of a radiomimetic chemical, bleomycin, in vitro. These challenged lymphocytes showed an MNNG dose-dependent increase of abnormal DNA repair response. In a population that was potentially exposed to teratogens - mothers having children with neural tube defects - lymphocytes from these mothers did not have the abnormal response in our assay. In studies with patients, we reported that lymphocytes from Down's syndrome patients have the abnormal DNA repair response. Lymphocytes from skin cancer-prone patients (epidermodysplasia verruciformis) have normal response to γ-ray challenge but abnormal response to UV-light challenge. These patient studies also indicate that the challenge assay is useful in documenting the radiosensitivity of Down's syndrome and the UV sensitivity in EV patients. In most cases, the challenge assay is more sensitive in detecting biological effects than the standard chromosome aberration assay. Our series of studies indicates that the challenge assay can be used to document biological effects from exposure to mutagens and that the effect is an abnormal DNA repair response. This abnormality can increase the risk for development of cancer. The repair deficiency is currently being validated using a plasmid transfection (host-reactivaton) assay. The need to integrate chromosome aberration and the challenge assays with other relevant assays for better documentation of biological effects and for more precise prediction of health risk will be presented. Our experience in using genetic polymorphism and host-reactivation assays will be discussed.

KW - Cancer susceptibility

KW - Chromosome aberrations

KW - DNA repair

KW - Environmental toxicology

KW - Genotoxicity

KW - Predisposition

UR - http://www.scopus.com/inward/record.url?scp=0029889351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029889351&partnerID=8YFLogxK

M3 - Article

C2 - 8781386

AN - SCOPUS:0029889351

VL - 104

SP - 579

EP - 584

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - SUPPL. 3

ER -